维普期刊资源整合服务平台（V6.5）

52篇 您的检索式：作者名="Slamon N D"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Role of anthracycline- based therapy in the adjuvant treatment of breast cancer: Efficacy analyses determined by molecular subtypes of the disease 显示文摘	Slamon D J Mackey J Robert N	2007	Breast Cancer Res Treat2007，106，：	1
2	Phase Ⅲ randomized trial comparing doxorubicin and cyclophosphamide followed by docetaxel (AC→T) with doxorubicin and cyclophosphamide followed by docetax- el and trastuzumab (AC→TH) with docetaxel, carboplatin and trastu- zumab(TCH) in HER2 positive early breast cancer patients: BCIRG 006 study显示文摘	Slamon D Eiermann W Robert N	2006	Breast Cancer Res Treat2006，100，1：	1
3	Adjuvant trastuzumab in HER2-Positive breast cancer显示文摘	Slamon D Eiermann W Robert N	2011	N Engl J Med2011，365，14：	1
4	Adjuvant trastuzumab in HER-2-posidve breast cancer显示文摘	Slamon D Eiermann W Robert N	2011	N Engl J Med2011，365，14：	1
5	Adjuvant trastuzumab in HER2-positive breast cancer显示文摘	Slamon D Eiermann W Robert N	2011	N Engl J Med2011，365，14：	1
6	Adjuvant trastuzumab in Her-2 positive breast cancer显示文摘	Slamon D Eiermann W Robert N	2011	N Engl J Med2011，365，14：	1
7	Phase Ⅲ randomized trial comparing doxorubicin and cyclophosphamide followed by docetaxel (AC/T) with doxorubicin and cyclophosphamide followed by docetaxel and trastuzumab (AC/ETH) with docetaxel, carboplatin and trastuzumab (TCH) in Her2neu positive early breast cancer patients: BCIRG 006 study显示文摘	SLAMON D EIERMANN W ROBERT N	2005	Breast Cancer Res Treat2005，94，1：	1
8	Phase III randomised trial comparing doxorubicin and cyclophosphamide followed by docetaxel with docorubicin and cyclophosphamide followed by docetaxel and trastuzumab with docetaxel, carboplatin and trastuzumab in HER2 positive early breast cancer patients: BCIRG006 study显示文摘	Slamon D Eiermann W Robert N	2005	Breast Cancer Res Treat2005，94，：	1
9	Adjuvant Trastuzumab in HER2 - Positive ,Breast Cancer 显示文摘	Slamon D Eiermann W Robert N	2011	N Engl J Med2011，365，14：	1
10	A adjuvant trastuzumab in HER2-positive breast cancer 显示文摘	Slamon D Eiermann W Robert N	2011	N Engl J Med2011，365，14：	1
11	Glutathione modifies the toxicity of triethyltin and trimethyltin in C6 glioma cells显示文摘	Slamon N D Pentreath V W	1998	Arch Toxicol1998，72，：	1
12	Adjuvant trastuzumab in HER,2-positive breast cancer 显示文摘	Slamon D Eiermann W Robert N	2011	N Engl J Med2011，365，14：	1
13	Phase Ⅲ randomized trial comparing doxorubicin and cyclophosphamide followed by do- cetaxel (AC→T) with doxorubicin and cyclophosphamide followed by docetaxel and trastuzumab (AC→TH) with docetaxel, carbopl- atin and trastuzumab (TCH) in Her2 positive early breast cancer patients: BCIRG 006 sudy 显示文摘	Slamon D Eiermann W Robert N	2009	Cancer Res2009，69，24：	1
14	Phase Ⅲ randomized trial comparing doxorubicin and cyclophosphamide followed by docetaxel ( ACT ) with doxorubicin and cyclophosphamide followed by docetaxel and trastuzumab (ACTH) with docetaxel, carboplatin, and trastuzumab (TCH) in HER2 positive early breast cancer patients: BCIRG 006 study 显示文摘	Slamon D Eiermann W Robert N	2005	Breast Cancer Res Treat2005，94，1：	1
15	BCIRG006:2nd interim analysis phase III randomized trial comparing doxorubicin and cyclophosphamide followed by docetaxel(AC/ET)with doxorubicin and cyclophosphamide followed by docetaxel and trastuzumab(AC/ETH)with docetaxel carboplatin and trastuzumab(TCH)in Her-2/neu positive early breast cancer patients显示文摘	Slamon D Eiermann W Robert N	2006	Breast Cancer Res Treat2006，10，：	1
16	Adjuvant trastuzumab in YiER2-positive breast cancer显示文摘	Slamon D Eiermann W Robert N	2011	N Engl J Med2011，365，14：	1
17	Phase Ⅲ randomized trial comparing doxorubicin and cyclophosphamide followed by docetaxel (AC-T) with doxorubicin and cyclophosphamide followed by docetaxel and trastuzumab (AC-TH) with docetaxel,carboplatin and trastuzumab (TCH) in HER2 positive early breast cancer patients:BCIRG 006 study显示文摘	Slamon D Eiermann W Robert N on behalf of the BCIRG 006 Investigators	2005	Breast Cancer Res Treat2005，94，：	1
18	Adjuvant trastuzumab in HER2-positive breast cancer显示文摘	Slamon D Eiermann W Robert N	2011	N Engl J Med2011，365，14：	1
19	Adjuvant Trastuzumab in HER2-Positive Breast Cancer显示文摘	Slamon D Eiermann W Robert N	2011	New Engl J Med2011，365，14：	1
20	Adjuvant trastuzumab in HER2-positive breast cancer 显示文摘	Slamon D Eiermann W Robert N	2011	N Engl J Med2011，365，14：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示